Biotech2 days ago
CAR-STAb: A Promising Dual-Action Immunotherapy for Resistant B-Cell Leukemia
Researchers developed CAR-STAb, a new immunotherapy combining CAR-T cells and bispecific antibodies, showing promise against B-cell malignancies in animal models. It recruits additional immune cells, blocking...